BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences, on receiving Investigational New Drug (IND) approval

Share the Post:

New meta-analysis: Early NMES after ACL surgery boosts quad strength. When and how should sports PTs use it? We break

Cranial Osteopathy Explained | London School of Osteopathy Written by London School of Osteopathy January 20, 2026 Cranial Osteopathy Explained:

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.

Related Posts